垂体生长激素腺瘤的研究及治疗进展

[1] 激素评估垂体生长激素腺瘤经蝶手术疗效 [J]. 中华神经医学杂志, 2006, (01) : 45 - 48

[2] 垂体生长激素腺瘤基因治疗的动物实验研究 [J]. 中国微侵袭神经外科杂志, 2004, (10) : 455 - 458

[3] α-干扰素和奥曲肽对垂体生长激素腺瘤的作用 [J]. 临床神经病学杂志, 2003, (01) : 28 - 30

[4] Glucose homeostasis and safety in patients with acromegaly converted from long-acting octreotide to pegvisomant [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (10) : 5684 - 5691

[5] Combined therapy with somatostatin analogues and weekly pegvisomant in active acromegaly [J]. LANCET, 2005, 365 (9471) : 1644 - 1646

[6] Medical treatment in acromegaly [J]. CURRENT OPINION IN PHARMACOLOGY, 2003, 3 (06) : 672 - 677

[7] Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist[J] . Aart Jan van der Lely,R Kent Hutson,Peter J Trainer,G Michael Besser,Ariel L Barkan,Laurence Katznelson,Anne Klibanski,Vivien Herman-Bonert,Shlomo Melmed,Mary Lee Vance,Pamela U Freda,Paul M Stewart,Keith E Friend,David R Clemmons,Gudmundur Johannsson,Stavros Stavrou,David M Cook,Lawrence S Phillips,Christian J Strasburger,Suzanne Hacker,Kenneth A Zib,Robert J Davis,John A Scarlett,Michael O Thorner.The

[8] INCIDENCE AND MANAGEMENT OF COMPLICATIONS OF TRANS-SPHENOIDAL OPERATION FOR PITUITARY-ADENOMAS [J]. NEUROSURGERY, 1987, 20 (06) : 920 - 924

[9] GS alpha and Gi2alpha mutations in clinically non-functioning pituitary tumors .2 Williamson EA,Daniels M,Foster S et al. Clin Endocrinol(Oxf) . 1994

[1] 激素评估垂体生长激素腺瘤经蝶手术疗效 [J]. 中华神经医学杂志, 2006, (01) : 45 - 48

[2] 垂体生长激素腺瘤基因治疗的动物实验研究 [J]. 中国微侵袭神经外科杂志, 2004, (10) : 455 - 458

[3] α-干扰素和奥曲肽对垂体生长激素腺瘤的作用 [J]. 临床神经病学杂志, 2003, (01) : 28 - 30

[4] Glucose homeostasis and safety in patients with acromegaly converted from long-acting octreotide to pegvisomant [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (10) : 5684 - 5691

[5] Combined therapy with somatostatin analogues and weekly pegvisomant in active acromegaly [J]. LANCET, 2005, 365 (9471) : 1644 - 1646

[6] Medical treatment in acromegaly [J]. CURRENT OPINION IN PHARMACOLOGY, 2003, 3 (06) : 672 - 677

[7] Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist[J] . Aart Jan van der Lely,R Kent Hutson,Peter J Trainer,G Michael Besser,Ariel L Barkan,Laurence Katznelson,Anne Klibanski,Vivien Herman-Bonert,Shlomo Melmed,Mary Lee Vance,Pamela U Freda,Paul M Stewart,Keith E Friend,David R Clemmons,Gudmundur Johannsson,Stavros Stavrou,David M Cook,Lawrence S Phillips,Christian J Strasburger,Suzanne Hacker,Kenneth A Zib,Robert J Davis,John A Scarlett,Michael O Thorner.The

[8] INCIDENCE AND MANAGEMENT OF COMPLICATIONS OF TRANS-SPHENOIDAL OPERATION FOR PITUITARY-ADENOMAS [J]. NEUROSURGERY, 1987, 20 (06) : 920 - 924

[9] GS alpha and Gi2alpha mutations in clinically non-functioning pituitary tumors .2 Williamson EA,Daniels M,Foster S et al. Clin Endocrinol(Oxf) . 1994